scholarly journals Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Sushma Chaubey ◽  
Sam Thueson ◽  
Devasena Ponnalagu ◽  
Mohammad Afaque Alam ◽  
Ciprian P. Gheorghe ◽  
...  
Keyword(s):  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Bronchopulmonary Dysplasia ◽  
Associated Factor

scholarly journals Mesenchymal Stem Cell-Mediated Reversal of Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension

2012 ◽  
Vol 2 (2) ◽  
pp. 170-181 ◽  
Author(s):  
Georg Hansmann ◽  
Angeles Fernandez-Gonzalez ◽  
Muhammad Aslam ◽  
Sally H. Vitali ◽  
Thomas Martin ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Bronchopulmonary Dysplasia

scholarly journals Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension

2019 ◽  
pp. 131-152 ◽  
Author(s):  
Vincent Yeung ◽  
Gareth R. Willis ◽  
Elizabeth Taglauer ◽  
S. Alex Mitsialis ◽  
Stella Kourembanas
Keyword(s):  
Pulmonary Hypertension ◽  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Bronchopulmonary Dysplasia ◽  
The Road

scholarly journals Application Prospects of Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia and the Challenges Encountered

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Yajie Tong ◽  
Jingye Zuo ◽  
Dongmei Yue
Keyword(s):  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Bronchopulmonary Dysplasia ◽  
Lung Tissue ◽  
Stem Cell Therapy ◽  
Research Progress ◽  
Mesenchymal Stem Cell Therapy ◽  
Stress Damage ◽  
Experimental Trials

Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in premature babies, especially affecting those with very low or extremely low birth weights. Survivors experience adverse lung and neurological defects including cognitive dysfunction. This impacts the prognosis of children with BPD and may result in developmental delays. The currently available options for the treatment of BPD are limited owing to low efficacy or several side effects; therefore, there is a lack of effective treatments for BPD. The treatment for BPD must help in the repair of damaged lung tissue and promote further growth of the lung tissue. In recent years, the emergence of stem cell therapy, especially mesenchymal stem cell (MSC) therapy, has improved the treatment of BPD to a great extent. This article briefly reviews the advantages, research progress, and challenges faced with the use of MSCs in the treatment of BPD. Stem cell therapy is beneficial as it repairs damaged tissues by reducing inflammation, fibrosis, and by acting against oxidative stress damage. Experimental trials have also proven that MSCs provide a promising avenue for BPD treatment. However, there are challenges such as the possibility of MSCs contributing to tumorous growths, the presence of heterogeneous cell populations resulting in variable efficacy, and the ethical considerations regarding the use of this treatment in humans. Therefore, more research must be conducted to determine whether MSC therapy can be approved as a treatment option for BPD.

Sign in / Sign up

Export Citation Format

Share Document